We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Wholehealth Products Inc (CE) | USOTC:GWPC | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 0.00 | 00:00:00 |
ANAHEIM, Calif., Nov. 17, 2014 /PRNewswire/ -- Headquartered in Anaheim, California, WholeHEALTH Products Inc. (OTC: GWPC) is a diversified company. WholeHEALTH Products Inc. is focused on leveraging the power and convenience of advanced technology and proven expertise of its team of professionals to improve the fundamental business of health and wellness. WholeHEALTH Products' comprehensive line of 22 professional diagnostic tests for hospitals, doctors, clinics and healthcare centers, and 8 retail consumer tests is your partner in the business of science.
WholeHEALTH Products Inc. announces completion of its Study for the Quantitative PCR Rapid Ebola Test, and is preparing to file with the FDA for Emergency Use Approval (EUA) later this month.
WholeHEALTH Products' PCE Rapid Diagnostic Ebola Whole Blood Test only takes a ground breaking 3 hours versus today's standard of care taking 2-3 days. As seen in the treatment of US patients to date, this amount of time-savings can be critical in the care and treatment of Ebola patients.
On November 12, 2014, the World Health Organization released a Situation Report stating Africa has reported 14,093 confirmed, probable and suspected cases of Ebola with the death toll of 5,155, which is up from 4,024 deaths reported October 10th. In the US, 2 of 4 patients lost the Ebola battle.
The need to stop the spread of Ebola is imperative due to the easy transmission of the virus, and the death rate of the victims. Human-to-human transmission occurs only via direct contact with blood or body fluid from an infected person (including embalming of an infected dead body), or by contact with objects contaminated by the virus. Other body fluids that may transmit Ebola viruses include saliva, mucus, vomit, feces, sweat, tears, breast milk, urine, and semen. Entry points include the nose, mouth, eyes, or open wounds, cuts and abrasions.
The sooner the disease is diagnosed, the sooner treatment can begin, and the better the chances of survival. WholeHEALTH Products' PCR Real Time Ebola Rapid Diagnostic Test will take only 3 hours. Their Rapid 15 Minute Lateral Flow Ebola Diagnostic Test is currently in Phase 3 and WholeHEALTH Product anticipates that to be completed by the end of November.
Inspired by its slogan, "Love Life Live Long," WholeHEALTH is committed to building long term relationships with the medical and healthcare professional and the patients, helping saves lives.
www.wholehealth-products.com
WholeHEALTH Products is your partner in the "Business of Science".
Certain information set forth in this fact sheet may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of WholeHEALTH Products Inc, including, but not limited to, risks associated with the impact of general economic conditions, industry conditions, dependence upon regulatory approvals, and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be
Logo - http://photos.prnewswire.com/prnh/20141103/156360
Photo - http://photos.prnewswire.com/prnh/20141117/159136
Photo - http://photos.prnewswire.com/prnh/20141117/159137
SOURCE WholeHEALTH Products Inc.
Copyright 2014 PR Newswire
1 Year Wholehealth Products (CE) Chart |
1 Month Wholehealth Products (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions